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Purpose: To evaluate the long-term outcomes of a surgical technique using a sutureless bovine 
pericardial patch graft for the implantation of an Ahmed glaucoma valve (AGV). 
Methods: This was a pilot study on patients with primary open-angle glaucoma refractory to repeated 
surgical filtering procedures. All patients underwent AGV implant technique using a sutureless bovine 
pericardial patch graft. The pericardial membrane was cut using an ordinary corneal trephine with a 
diameter of 9.0 or 10.0 mm. The anterior part of the tube was covered with the graft and kept in place 
with fibrin glue. Subsequently, the cap was stitched all around the tube and the dissected conjunctiva 
was laid over it. Intraocular pressure (IOP) and complications were evaluated 1 week and 1, 3, 6, 12, 
and 24 months after surgery.
Results: The procedure was used to treat 20 eyes of 20 consecutive patients (12 men and 8 women: 
mean age [SD] 64.8 [7.8] years). Mean IOP was 28.1 mm Hg (SD 4.9) at baseline and decreased to 
14.9 mm Hg (SD 1.5) 24 months after surgery (p<0.001). The overall mean number of topical medica-
tions was 3.1 (SD 0.5) at baseline and decreased to 1.4 (SD 0.8) after 24 months (p<0.001). During 
follow-up, there was no conjunctival erosion, thinning of pericardial patch graft over the tube, or tube 
exposure; no signs of endophthalmitis were recorded.
Conclusions: The results suggest that the sutureless technique using a bovine pericardial graft patch 
is a safe and rapid procedure for AGV implantation.
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INTRODUCTION
The practice of implanting a glaucoma drainage device 
(GDD) in patients with surgically refractory glaucoma is 
rapidly growing (1, 2). Glaucoma drainage devices lower 
intraocular pressure (IOP) by creating a space between the 
sclera and the conjunctiva within which aqueous humor 
may flow. The distal end of the tube can be inserted into 
the anterior chamber or vitreous cavity. However, if left 
uncovered, the extraocular part of the tube can erode the 
conjunctiva, and this represents a major risk factor for en-
dophthalmitis (3, 4). Various tissue patch grafts have been 
proposed for covering the distal part of the tube (human 
donor dura mater, fascia lata, human donor sclera, and 
pericardial tissue) (5-8). The patches of different materials 
and sizes are anchored to the bulbar sclera using 9-0 or 
10-0 nylon sutures, or 7-0 polyglactin sutures. Zeppa et al 
(9) have recently proposed a sutureless human sclera 
donor patch technique for Ahmed glaucoma valve (AGV) 
implantation, but its use has been limited by costs, com-
mercial availability, and the poor uniformity and quality of 
donor sclera. In this study, we present the outcomes of 
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a sutureless procedure for AGV implant using Tutopatch® 
(Tutogen Medical GmbH, Neunkirken am Brand, Germany).
METHODS
Twenty eyes of 20 consecutive patients (12 men and 
8 women; mean age [SD] 64.8 years [7.8]) with primary 
open-angle glaucoma (POAG) refractory to repeated sur-
gical filtering procedures (previous surgeries, mean [SD] 
2.7 [0.8]) who were receiving maximal tolerated medical 
therapy were treated (defined as 3-4 topical drugs in fixed 
or unfixed combinations). All of the operations were per-
formed by an expert glaucoma surgeon (L.Q.) working at 
the Glaucoma Service of the University of Brescia.
Informed consent was obtained from all the studied sub-
jects. A fornix-based conjunctival incision was made in 
the superotemporal quadrant, and a blunt dissection was 
performed. After identifying the 2 adjacent rectus mus-
cles, the AGV (Model S2, New World Medical, Rancho 
Cucamonga, Louisiana, USA) was implanted between 
them approximately 10 mm posterior to the surgical lim-
bus. The plate was then secured to the sclera using inter-
rupted 10-0 nylon sutures (Alcon Surgical, Milan, Italy), 
and the tube inserted into the anterior chamber through 
a scleral fistula created by means of a 23-gauge needle. 
Tutopatch® is a collagen membrane that is extracted from 
solvent-preserved bovine pericardium sterilized by means of 
gamma radiation. Before use, the collagen membrane was 
rehydrated with saline solution for 5-10 minutes, and the 
membrane was then cut using an ordinary corneal trephine 
with a diameter of 9.0 or 10.0 mm. The anterior edge of the 
patch graft was positioned just anterior to the tube insertion, 
and kept in place with fibrin glue (Tisseel fibrin glue, Baxter 
AG, Vienna, Austria) (Fig. 1A). Subsequently, the cap was 
stitched all around the tube and the dissected conjunctiva 
was laid over it (Fig. 1B); fibrin glue was then applied to the 
underside of the conjunctiva and smooth forceps were used 
to hold the edges in place until adherence was assured, tak-
ing care to cover the graft totally (Fig. 1C). The eye was then 
examined for leaks as the anterior chamber was filled with 
balanced salt solution through a paracentesis.
The IOP and complications were evaluated 1 week and 
1, 3, 6, 12, and 24 months after surgery. Success was de-
fined as an IOP of ≤18 mm Hg, with (qualified success) or 
without medical hypotensive therapy (complete success) 
in all study visits during 2-year follow-up.
Fig. 1 - (A) The patch graft is positioned just anterior to the tube 
insertion, and kept in place with fibrin glue. (B) The patch graft is 
stitched all around the tube by using fibrin glue. (C) Final result: full 
approximation of the conjunctiva to the limbus.
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The comparison of the postoperative IOP values with the 
baseline was performed by means of the paired t test. The 
Bonferroni approach was adopted in order to make allow-
ance for multiple tests; therefore, statistical significance 
level was set to 0.008, calculated as 0.05 divided by 6 
comparisons.
The time to treatment failure was calculated as the time 
from the date of registration to the date in which the IOP 
was >18 mm Hg; patients with an IOP always within the 
normal values were censored at the end of observation in-
terval. Time to treatment failure was described using the 
Kaplan-Meier method.
RESULTS
Sixteen patients (80%) were followed up for two years with 
an IOP ≤18 mmHg; the remaining four patients withdrew 
due to not sufficiently controlled IOP (Fig. 2). At the end of 
taBle i -  INTRAOCULAR PRESSURE AND MEDICAL HYPOTENSIVE THERAPYa
Baseline 1 wk 1 mo 3 mo 6 mo 1 y 2 y
IOP, mm Hg 28.1 (4.9) 8.1 (3.1) 13.5 (2.8) 14 (2.2) 14.3 (2.3) 14.7 (2.2) 14.9 (1.5)
Paired t testb (p value) <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Glaucoma medications 3.1 (0.5) 0 0.5 (0.6) 0.9 (0.7) 1.2 (0.7) 1.3 (0.8) 1.4 (0.8)
Paired t testb (p value) <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
IOP = intraocular pressure.
aResults are reported as mean (SD).
bComparison versus baseline.
Fig. 2 - Ahmed glaucoma valve implantation: time to treatment 
failure.
taBle ii -  POSTOPERATIVE COMPLICATIONS AFTER 
AHMED GLAUCOMA VALVE IMPLANTATION
Complicationsa no. (%) of eyes
Increased intraocular pressureb 4 (20)
Hypotonyc 2 (10)
Shallow or flat anterior chamber 3 (15)
Anterior chamber bleeding 2 (10)
Choroidal effusion 4 (20)
aSome patients had more than one complication.
bIntraocular pressure >21 mm Hg during maximal medical therapy.
cIntraocular pressure <6 mm Hg.
Fig. 3 - Patch graft 2 years after Ahmed glaucoma valve implantation.
the 2-year follow-up, complete and qualified success was 
obtained in 3 and 13 eyes respectively. In the 16 patients 
followed up for 2 years, the IOP significantly decreased 
from the first postoperative visit to the end of the follow-up 
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patch.
The reported sutureless surgical technique is similar to that 
described by Kahook and Noecker (15). However, differ-
ently from our technique, they had applied a 6 × 6-mm bo-
vine pericardial patch graft at the level of tube entry site, 
sealed with fibrin glue. There is a substantial advantage to 
using a round patch graft of 9.0 to 10.0 mm in diameter. 
As a matter of fact, it allows to cover the majority of the 
length of the tube, and it offers greater safety in avoiding 
conjunctival erosion and tube exposure.
Limitations of the present study include limited follow-up, 
small sample size, and lack of inclusion of cases more at 
risk for conjunctival erosion (uveitic glaucoma, congenital 
and juvenile glaucoma). 
In conclusion, this sutureless technique using a bovine 
pericardial graft patch seems to be a safe and rapid pro-
cedure for AGV implantation. There is a need for longer 
follow-up in order to determine whether there are any long-
term complications.
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after 24 months (mean IOP preoperatively 28.1 mm Hg [SD 
4.9], mean IOP 24 months postoperatively 14.9 mm Hg [SD 
1.5]; p<0.001). In all the follow-up visits, the number of top-
ical hypotensive medications was significantly decreased 
when compared with the baseline (p<0.001) (Tab. I).
Table II shows the postoperative complications. Through-
out the period of follow-up, there was no conjunctival ero-
sion, thinning of the patch graft over the anterior part of the 
tube, or tube exposure; no signs of endophthalmitis were 
recorded (Fig. 3).
DISCUSSION
The advantages of using fibrin glue in ocular surgery are 
well-known and include a shorter operative time and less 
postoperative pain (10-13). Furthermore, the absence of 
sutures is also of some advantage postoperatively, be-
cause they can promote inflammation and provide a nidus 
for infection or neovascularization.
As the components of fibrin glue often come from pooled 
human plasma, there is a theoretical risk of human disease 
transmission. However, to our knowledge, there have not 
been any documented cases of disease transmission de-
spite the extensive use of these products in various surgi-
cal fields (14), and so the risk appears to be minimal. The 
total sterility of the Tutopatch® material is guaranteed by 
gamma radiation and chemical treatments. The relatively 
high cost of fibrin glue is counterbalanced by the low cost 
of Tutopatch®, when compared with human sclera donor 
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